6.15. Analysis.

Comparison 6: Bamlanivimab in hospitalised individuals with COVID‐19 (moderate and severe disease), Outcome 15: Renal dysfunction (or need for dialysis) by day 30

Comparison 6: Bamlanivimab in hospitalised individuals with COVID‐19 (moderate and severe disease), Outcome 15: Renal dysfunction (or need for dialysis) by day 30